Hyperactivity following postnatal NMDA antagonist treatment: Reversal by D-amphetamine

Neurotoxicity Research

Volumn 5, Issue 7, 2003, Pages 549-564

  Fredriksson, Anders ^a   Archer, Trevor ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Activity; ADHD; d Amphetamine; Degeneration; Ethanol; Fluoro jade; Habituation; Hyperactivity; Ketamine; Locomotion; MK 801; Rearing

Indexed keywords

ALCOHOL; AMINO ACID RECEPTOR BLOCKING AGENT; CENTRAL DEPRESSANT AGENT; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; DIZOCILPINE MALEATE; FLUORESCENT DYE; FLUORO JADE; KETAMINE; N METHYLASPARTIC ACID; ORGANIC COMPOUND;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BRAIN; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HABITUATION; HYPERKINESIA; MALE; MOTOR ACTIVITY; MOUSE; PATHOLOGY; PREGNANCY; WEIGHT GAIN;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DIZOCILPINE MALEATE; ETHANOL; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FLUORESCENT DYES; HABITUATION, PSYCHOPHYSIOLOGIC; HYPERKINESIS; KETAMINE; MALE; MICE; MOTOR ACTIVITY; N-METHYLASPARTATE; ORGANIC CHEMICALS; PREGNANCY; WEIGHT GAIN;

EID: 1342285201     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033165     Document Type: Article

References (96)

1. Archer T, A Fredriksson, G Jonsson, T Lewander, AK Mohammed, SB Ross and U Söderberg (1986) Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat. Psychopharmacology (Berl.) 88, 141-146.
2. Archer T, T Palomo and A Frediksson (2002a) Functional deficits following neonatal dopamine depletion and isolation housing: Circular water maze acquisition under pre-exposure conditions and motor activity. Neurotoxicity Res. 4, 503-522.
3. Archer T, T Palomo and A Frediksson (2002b) Neonatal 6-hydroxydopamine-induced hypo/hyperactivity: Blockade by dopamine reuptake inhibitors and effect of acute d-amphetamine. Neurotoxicity Res. 4, 247-266.
4. Barkley RA (1977) A review of stimulant drug research with hyperactive children. J. Child Psychol. Psychiatry 18, 137-165.
5. Barkley RA (1997) Behavioural inhibition, sustained attention and executive functions: Constructing a unifying theory of ADHD. Psychol. Bull. 121, 65-94.
6. Barkley RA, M Fischer, CS Edelbrock and L Smallish (1990) The adolescent outcome of hyperactive children diagnosed by research criteria. I. An 8-year prospective follow-up study. J. Am. Acad. Child Adolesc. Psychiatry 29, 546-557.
7. Barkley RA, GJ DuPaul and MB McMurray (1991) Attention deficit disorder with and without hyperactivity: Clinical response to three different doses of methylphenidate. Pediatrics 87, 519-531.
8. Berquin PC, JN Giedd, LK Jacobsen, SD Hamburger, AL Krain, JL Rapoport and FX Castellanos (1998) Cerebellum in attention-deficit hyperactivity disorder - a morphometric MRI study. Neurology 50, 1087-1093.
9. Biederrman J and T Spencer (1999) Attention-defict/hyperactivity disorder (ADHD) is a noradrenergic disorder. Biol. Psychiatry 46, 1234-1242.
10. Biederrman J, RJ Baldessarini, V Wright, D Knee and JS Harmatz (1989) A double-blind placebo controlled study desipramine in the treatment of ADD I. Efficacy. J. Am. Acad. Child Adolesc. Psychiatry 28, 777-784.
11. Biederrman J, J Newcorn and S Sprich (1991) Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am. J. Psychiatry 148, 564-577.
12. Blaze CA, RE Holland and AL Grant (1988) Gas exchange during xylazine-ketamine anesthesia in neonatal calves. Veterinary Surg. 17, 155-159.
13. Bymaster FP, JS Katner, DL Nelson, SK Hemrick-Luecke, PG Threlkeld, JH Heiligenstein, SM Morin, DR Gehlert and KW Perry (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27, 699-711.
14. Byrnes ML, JN Reynolds and JF Brien (2001) Effect of prenatal ethanol exposure during the brain growth spurt of the guinea pig. Neurotoxicol. Teratol. 23, 355-364.
15. Castellanos FX, J Elia, MJ Kruesi, WL Marsh, CS Gulotta, WZ Potter, GF Ritchie, SD Hanburger and JL Rapoport (1996a) Cerebrospinal fluid homovanillic acid predicts behavioural response to stimulants in 45 boys with attention deficit/hyperactivity tivity disorder. Neuropsychopharmacology 14, 125-137.
16. Castellanos FX, JN Giedd, WL Marsh, SD Hamburger, AC Vaituzis, DP Dickstein, SE Sarfatti, YC Vauss, JW Snell, N Lange, D Kaysen, AL Krain, GF Ritchie, JC Rajapakse and JL Rapoprt (1996b) Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 53, 607-616.
17. Chen WA, SE Parnell and JR West (1999) Early postnatal alcohol exposure produced long-term deficits in brain weight, but not the number of neurons in the locus coeruleus. Brain Res. Dev. Brain Res. 118, 33-38.
18. Clarren SK and DW Smith (1978) The fetal alcohol syndrome. N. Engl. J. Med. 298, 1063-1067.
19. Danielsson BR, A Fredriksson, L Dahlgren, AT Gardlund, L Olsson, LL Dencker and T Archer (1993) Behavioural effects of prenatal metallic mercury inhalation exposure in rats. Neurotoxicol. Teratol. 15, 391-396.
20. Danneman PJ and TD Mandrell (1997) Evaluation of five agents/methods for anesthesia of neonatal rats. Lab. Anim. Sci. 47, 386-395.
21. Davison AN and J Dobbing (1968) Applied Neurochemistry (Blackwell: Oxford), pp 253-316.
22. Dougherty DD, AA Bonab, TJ Spencer, SL Rauch, BK Madras and AJ Fischman (1999) Dopamine transport density in patients with attention deficit hyperactivity disorder. Lancet 354, 2132-2133.
23. Downey KK, FW Stelson, OF Pomerleau and B Giordani (1997) Adult attention deficit hyperactivity disorder: Psychological test profiles in a clinical population. J. Nerv. Ment. Disord. 185, 32-38.
24. 99Tc]TRODAT-1 to the dopamine transporter before and after methylphenidate. Eur. J. Nucl. Med. 27, 1518-1524.
25. Eckardt MJ, SE File, GL Gessa, KA Grant, C Guerri, PL Hoffman, H Kalant, GF Koob, TK Li and B Tabakoff (1998) Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin. Exp. Res. 22, 998-1040.
26. Elia J, BG Borcheding, JL Rapoport and CS Keysor (1991) Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true responders? Psychiatry Res. 36, 141-155.
27. Elia J, P Ambrosini and JL Rapoport (1999) Treatment of attention-deficit hyperactivity disorder. N. Engl. J. Med. 340, 780-788.
28. Eng M, JJ Bonica, TJ Akamatsu, PU Berges and K Ueland (1975) Respiratory depression in newborn monkeys at Caesarian section following ketamine administration. Br. J. Anaesth. 47, 917-921.
29. 18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am. J. Psychiatry 156, 1209-1215.
30. Famy C, AP Streissguth and AS Unis (1998) Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects. Am. J. Psychiatry 155, 552-554.
31. Filipek PA, M Semrud-Clikeman, RJ Steingard, PF Renshaw, DN Kennedy and J Biederman (1997) Volumetric MRI analysis compating attention-deficit hyperactivity disorder and normal controls. Neurology 48, 589-601.
32. Fredriksson A and T Archer (2002) Functional alteration by NMDA antagonist: Effects of L-Dopa, neuroleptic drugs and postnatal administration. Amino Acids 23(1-3), 111-132.
33. Fredriksson A, L Dahlgren, B Danielsson, P Eriksson, LL Dencker and T Archer (1992) Behavioural effects of neonatal metallic mercury exposure in rats. Toxicology 74(2-3), 151-160.
34. Fredriksson A, N Schroder, P Eriksson, I Izquierdo and T Archer (1999) Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol. Appl. Pharmacol. 159, 25-30.
35. Fredriksson A, N Schroder, P, Eriksson, I Izquierdo and T Archer (2000) Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Brain Res. Dev. Brain Res. 119, 65-74.
36. Fredriksson A, N Schroder, P Eriksson, I Izquierdo and T Archer (2001) Neonatal iron potentiates adult MPTP-induced neurode-generative and functional deficits. Parkinsonism Relat. Disord. 7, 97-105.
37. Fredriksson A, N Schroder and T Archer (2003) Neurobehavioural deficits following postnatal iron overload: I Spontaneous motor activity. Neurotoxicity Res. 5(1-2), 53-76.
38. Goodyear P and GW Hynd (1992) Attention-deficit disorder with (ADD/H) and without (ADD/WO) hyperactivity: Behavioral and neuropsychological differentiation. J. Clin. Child Psychol. 21, 273-305.
39. Gorter JA and JP de Bruin (1992) Chronic neonatal MK-801 treatment results in impairment of spatial learning in the adult rat. Brain Res. 580, 12-17.
40. Greenhill L (1995) Attention-deficit/hyperactivity disorder: The stimulants. Child Adolesc. Psychiatr. Clin. North. Am. 4, 123-168.
41. Guerri C (1998) Neuroanatomical and neurophysiological mechanisms involved in central nervous system dysfunctions induced by prenatal alcohol exposure. Alcohol Clin. Exp. Res. 22, 304-312.
42. Hodgkinson R, GF Marx, SS Kim and M Miclat (1977) Neonatal neurobehavioural tests following vaginal delivery under ketamine, thiopental, and extradural anesthesia. Anesth. Analg. 56, 584A.
43. Hodgkinson R, M Bhatt, SS Kim, G Grewal and GF Marx (1978a) Neonatal neurobehavioral tests following cesarian section under general and spinal anesthesia. Am. J. Obstet. Gynecol. 132, 670-674.
44. Hodgkinson R, m Bhatt and CN Wang (1978b) Double-blind comparison of the neurobehaviour of neonates following the administration of different doses of meperidine to the mother. Can. Anaesth. Soc. J. 25, 405-411.
45. Ikonomidou C, F Bosch, M Miksa, P Bittigau, J Vockler, K Dikranian, T Tenkova, V Stefovska and JW Olney (1999) Blockade of NMDA receptors and apoptofic neurodegeneration in the developing brain. Science 283, 70-74.
46. Ikonomidou C, P Bittigau, MJ Ishimaru, DF Wozniak, C Koch, K Genz, MT Price, V Stefovska, F Hörster, T Tenkova, K Dikranian and JW Olney (2000) Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287, 1056-1060.
47. Ikonomidou C, P Bittigau, C Koch, K Genz, MT Price, F Hörster, U Felderhoff-Mueser, T Tenkova, K Dikranian and JW Olney (2001) Neurotransmitters and apoptosis in the developing brain. Biochem. Pharmacol. 62, 401-405.
48. Ishimaru MJ, C Ikonomidou, TI Tenkova, TC Der, K Dikranian, MA Sesma and JW Olney (1999) Distinguishing excitotic from apoptotic neurodegeneration in the developing rat brain. J. Comp. Neurol. 408, 461-476.
49. Kalat JW (2001) Biological Psychology (Wadsworth/Thomson Learning. Belmont CA).
50. Kirk RE (1995) Experimental Design. Procedures in Behavioural Science. (Brooks/Cole Inc., Belmont CA).
51. Krause K-H, SH Dresel, J Krause, HF Kung and K Tatsch (2000) Increased striatal dopamine transporter in acult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci. Lett. 285, 107-110.
52. Lafond JS, JC Fouron and H Bard (1987) Cardiovascular status during ketamine anesthesia in the fetal lamb. Biol. Neonate 52, 279-284.
53. Lou HC, L Henricksen, P Bruhn, H Borner and JB Nielsen (1989) Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch. Neurol. 46, 48-52.
54. Lynam DR (1996) Early identification of chronic offenders: Who is the fledgling psychopath? Psychol. Bull. 120, 209-234.
55. Lynam DR (1998) Early identification of the fledgling psychopath: locating the psychopathic child in the current nomenclature. J. Abnorm. Psychol. 107, 566-575.
56. Madras B (2002) Brain imaging of the dopamine transporter in ADHD. Behav. Brain Res. 130, 57-63.
57. Mariani MA and RA Barkley (1997) Neuropsychological and academic functioning in preschool boys with attention deficit hyperactivity disorder. Dev. Psychol. 13, 111-129.
58. Manuzza S, RG Klein, A Bessler, P Malloy and M LaPadula (1993) Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch. Gen. Psychiatry 50, 565-576.
59. Manuzza S, RG Klein, A Bessler, P Malloy and M LaPadula (1998) Adult psychiatric status of hyperactive boys grown up. Arch. Gen. Psychiatry 55, 493-498.
60. Mickley GA, DR Remmers-Roeber, C Crouse and R Peluso (2000) Ketamine blocks a taste recognition memory in fetal rats. Pharmacol. Biochem. Behav. 67, 575-581.
61. Mickley GA, DR Remmers-Roeber, CM Dengler, CL Kenmuir and C Crouse (2001) Paradoxical effects of ketamine on the memory of fetuses of different ages. Brain Res. Dev. Brain Res. 127, 71-76.
62. Moghaddam B, B Adams, A Verma and D Daly (1997) Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17, 2921-2927.
63. Mostofsky SH, AG Lasker, LE Cutting, MB Denckla and DS Zee (2001) Oculomotor abnormalities in attention deficit hyperactivity disorder: A preliminary study. Neurology 57, 423-430.
64. Nieoullon A (2002) Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 67, 53-83.
65. Olney JW, J Labruyere and MT Price (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360-1362.
66. Olney JW, DF Wozniak, V Jevtovic-Todorovic and C Ikonomidou (1991) NMDA antagonist neurotoxicity: Mechanism and prevention. Science 254, 1515-1518.
67. Olney JW, NB Farber, DF Wozniak, V Jevtovic-Todorovic and C Ikonomidou (2000) Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain. Environ. Health Prospect. 108(Suppl 3), 383-388.
68. Olney JW, T Tenkova, K Dikranian, YQ Qin, J Labruyere and C Ikonomidou (2002) Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain. Brain Res. Dev. Brain Res 133(2), 115-126.
69. Raol YH, DR Lynch and AR Brooks-Kayal (2001) Role of excitatory amino acids in developmental epilepsies. Ment. Retard. Dev. Disabil. Res. Rev. 7, 254-260.
70. Rapport MD, KM Chung, G Shore, CB Denney and P Isaacs (2000) Upgrading the science and technology of assessment and diagnosis: Laboratory and clinic-based assessment of children with ADHD. J. Clin. Child Psychol. 29, 555-568.
71. Riva D and C Giorgi (2000) The cerebellum contributes to higher functionsSduring development: Evidence from: series of children surgically treated for posterior fossa tumours. Brain 123, 1051-1061.
72. Roegge CS, BW Seo, KM Crofton and SL Schantz (2000) Gestation-lactation exposure to aroclor 1254 impairs radial-arm maze performance in male rats. Toxicol. Sci. 57, 121-130.
73. Rubia K, J Oosterlaan, JA Sergeant, D Brandeis and T Leeuwen (1998) Inhibitory dysfunction in hyperactive boys. Behav. Brain Res. 94, 25-32.
74. Rubia K, S Overmeyer, E Taylor, M Brammer, SC Williams, A Simmons and ET Bullmore (1999) Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI. Am. J. Psychiatr. 156, 891-896.
75. Schmued LC and KJ Hopkins (2000) Fluoro-jade: Novel fluorochromes for detecting toxicant induced neuronal degeneration. Toxicol. Pathol. 28, 91-99.
76. Schmued LC, C Albertson and W Slikker (1997) Fluoro-jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751, 37-46.
77. Schweitzer JB, TL Faber, ST Grafton, LE Tune, JM Hoffman and CD Kilts (2000) Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. Am. J. Psychiatr. 157, 278-280.
78. Shaywitz BA, JH Klopper, RD Yager and JW Gordon (1976) Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine. Nature 261, 153-155.
79. Shaywitz BA, JW Gordon, JH Klopper and DA Zelterman (1977) The effect of 6-hydroxydopamine on habituation of activity in the developing rat pup. Pharmacol. Biochem. Behav. 6, 391-396.
80. Solanto MV (1998) Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behav. Brain Res. 94, 127-152.
81. Solanto MV (2002) Dopamine dysfunction in AD/HD: Integrating clinical and basic science research. Behav. Brain Res. 130, 65-71.
82. Spencer T, T Wilens, J Biederman, SV Faraone, S Ablon and K Lapey (1995) A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention deficit hyperactivity disorder. Arch. Gen. Psychiatry 52, 434-443.
83. Spencer T, J Biederman, T Wilens, M Harding, D O'Donnell and S Griffin (1996) Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J. Am. Acad. Child Adolesc. Psychiatry 35, 409-432.
84. Spencer T, J Biederman, T Wilens, J Prince, M Hatch, J Jones, M Harding, SV Faraone and L Seidman (1998) Effectiveness and tolerability of atomoxetine in adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 155, 693-695.
85. Spencer T, J Biederman, J Heiligenstein, T Wilens, D Faries, J Prince, SV Faraone, J Rea, J Witcher and S Zervas (2001) An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 11, 251-265.
86. Swanson JM, JA Sergeant, E Taylor, EJS Sonuga-Barke, PS Jensen and DP Cantwell (1998) Attention deficit hyperactivity disorder and hyperkynetic disorder. Lancet 351, 329-343.
87. Swanson JM, P Flodman, J Kennedy, MA Spence, R Moyzis, S Schuck, M Murias, J Moriaty, C Barr, M Smith and M Posner (2000) Dopamine genes and ADHD. Neurol. Biobehav. Rev. 24, 21-25.
88. Szatmari P (1992) The edidemiology of attention-deficit hyperactivity disorder. Child Adolesc. Psychiatry Clin. North Am. 1, 361-371.
89. Viggiano D, G Grammatikopoulos and A Sadile (2002) A morphometric evidence for a hyperfunctioning mesolimbic system in an animal model of ADHD. Behav. Brain Res. 130, 181-189.
90. Volkow ND, G Wang, JS Fowler, SJ Gatley, J Logan, Y-S Ding, R Hitzemann and N Pappas (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry 155, 1325-1331.
91. Volkow ND, G Wang, JS Fowler, J Logan, M Gerasimov, L Maynard, Y-S Ding, SJ Gatley, A Gifford and D Franceschi (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J. Neurosci. 21, RC121, 1-5.
92. Weiss G and L Hechtman (1979) The hyperactive child syndrome. Science 205, 1348-1354.
93. West JR, CR Goodlett, DJ Bonthius and DR Pierce (1989) Manipulating peak blood alcohol concentrations in neonatal rats: Review of an animal model for alcohol-related developmental effects. Neurotoxicology 10, 347-365.
94. Wilens TE, J Biederman, J Prince, TJ Spencer, SV Faraone, R Warburton, D Schleifer, M Harding, C Linehan and D Geller (1996) Six-week, double-blind, placebo controlled study of desipramine for adult attention deficit hyperactivity disorder. Am. J. Psychiatry 153, 1147-1153.
95. Wilens TE and TJ Spencer (2000) The stimulants revisited. Child Adolesc. Clin. North Am. 9, 573-603.
96. Zametkin AJ, TE Nordahl, M Gross, AC King, WE Semple, J Rumsey, S Hamburger and RM Cohen (1990) Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N. Engl. J. Med. 323, 1361-1366.